US Patent Issued to ONO PHARMACEUTICAL on Nov. 4 for "Salt and crystal form of compound having agonistic activity to S1P5 receptor" (Japanese, American Inventors)

ALEXANDRIA, Va., Nov. 6 -- United States Patent no. 12,459,890, issued on Nov. 4, was assigned to ONO PHARMACEUTICAL Co. LTD. (Osaka, Japan).

"Salt and crystal form of compound having agonistic activity to S1P5 receptor" was invented by Shuhei Otani (Osaka, Japan), Takayuki Fujito (Osaka, Japan), Naoko Imura (Osaka, Japan), Hideomi Kijima (Osaka, Japan), Stephan D. Parent (Osaka, Japan), Melanie Janelle Bevill (West Lafayette, Ind.), Courtney S. Johnson (West Lafayette, Ind.) and Travis Lee Houston (Lafayette, Ind.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compound I as defined, having high S1P5 receptor-selective agonist activity on the S1P1 receptor, and the crystal forms of Compound I, the salts of C...